Enhancing the efficacy of immunotherapy in lung cancer

Enhancing the efficacy of immunotherapy in lung cancer

BioPharma Enhancing the efficacy of immunotherapy in non-small cell lung cancer using an RGD-mimetic Queen Mary scientists led by Prof Kairbaan Hodivala-Dilke have invented a new methodology for treating lung cancer – the leading cause of cancer deaths...
A Combination Therapy for Neovascular Eye Diseases

A Combination Therapy for Neovascular Eye Diseases

BioPharma A Combination Therapy for Neovascular Eye Diseases Angiogenesis is a leading cause of eye problems among over 50s – including blindness. Conventional treatments have serious side effects, making them deeply unpleasant for patients. A new peptide therapy...